Logo

mass cytometry

Fluidigm Q2 Revenues Grow 19 Percent

The firm noted that its base product and service revenue (excluding COVID-19 testing) increased 33 percent year over year to $26.9 million.

Fluidigm Inks Comarketing Pacts With Ultivue, ImaBiotech

The separate comarketing agreements with Ultivue and ImaBiotech are related to Fluidigm's Imaging Mass Cytometry technology platform.

Maternal Blood Proteomic, Metabolomic Changes Could Predict Onset of Labor

About two to four weeks before labor starts, changes affecting the maternal metabolome, proteome, and immunome occur, a new study found.

Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID
Premium

Fluidigm CEO Chris Linthwaite said the company aims to further penetrate the diagnostic and clinical markets with both its microfluidics and mass cytometry businesses.

Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth

The firm also announced a COVID-19 testing deal with George Mason University and a CyTOF supply and distribution agreement with Zhejiang PuLuoTing Health Technology in China.

Feb 10, 2021

ImmunoScape, Johns Hopkins Team Profiles T Cell Response in COVID-19 Patients
Premium

Nov 5, 2020

Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing

Aug 10, 2020

T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma

Aug 4, 2020

Fluidigm, De Novo Software Ink Distribution Deal

Jul 14, 2020

Newly Proposed B Cell Atlas Identifies 12 Unique Subsets

May 7, 2020

Fluidigm Q1 Revenues Fall 8 Percent

Apr 30, 2020

Washington University, BostonGene Expand Kidney Cancer Research Collaboration

Feb 26, 2020

Fluidigm Acquires Cytometry Sample Prep Firm InstruNor for $7.2M

Feb 10, 2020

Fluidigm Reports Flat Q4 Revenues

Jan 24, 2020

Federal Court Whittles Down Fluidigm Lawsuit Against IonPath

Jan 21, 2020

Imaging Mass Cytometry Uncovers Novel Breast Cancer Subgroups Associated With Outcomes

Jan 14, 2020

Fluidigm Anticipates Flat Q4 Revenues

Nov 5, 2019

Fluidigm Q3 Revenues Fall 9 Percent on Mass Cytometry Weakness

Sep 10, 2019

Fluidigm Sues IonPath for Patent Infringement, Interference

Aug 1, 2019

Fluidigm Q2 Revenues Grow 7 Percent; Stock Tumbles on Microfluidics Weakness, Soft Guidance

May 3, 2019

Fluidigm Q1 Revenues Soar 19 Percent

Apr 11, 2019

Fluidigm's New Immune Cell Profiling Assay Could Boost Use of Mass Cytometry
Premium

Feb 7, 2019

Fluidigm Q4 Revenues Grow 17 Percent on Mass Cytometry Strength

Nov 1, 2018

Fluidigm Q3 Revenues Up 17 Percent

Oct 9, 2018

10,000 Immunomes Project Establishes Initial Baseline for Healthy Immune System

Breaking News
The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.